212 related articles for article (PubMed ID: 22133306)
1. Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.
Riday TT; Fish EW; Robinson JE; Jarrett TM; McGuigan MM; Malanga CJ
Brain Res; 2012 Jan; 1431():53-61. PubMed ID: 22133306
[TBL] [Abstract][Full Text] [Related]
2. Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward.
Hutcheson DM; Quarta D; Halbout B; Rigal A; Valerio E; Heidbreder C
Behav Pharmacol; 2011 Apr; 22(2):173-81. PubMed ID: 21285875
[TBL] [Abstract][Full Text] [Related]
3. Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization.
Sharf R; Guarnieri DJ; Taylor JR; DiLeone RJ
Brain Res; 2010 Mar; 1317():24-32. PubMed ID: 20034477
[TBL] [Abstract][Full Text] [Related]
4. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking.
Smith RJ; See RE; Aston-Jones G
Eur J Neurosci; 2009 Aug; 30(3):493-503. PubMed ID: 19656173
[TBL] [Abstract][Full Text] [Related]
5. Orexin/hypocretin is necessary for context-driven cocaine-seeking.
Smith RJ; Tahsili-Fahadan P; Aston-Jones G
Neuropharmacology; 2010 Jan; 58(1):179-84. PubMed ID: 19591850
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the orexin/hypocretin system in ethanol conditioned place preference.
Voorhees CM; Cunningham CL
Psychopharmacology (Berl); 2011 Apr; 214(4):805-18. PubMed ID: 21107540
[TBL] [Abstract][Full Text] [Related]
7. Role of orexin/hypocretin in conditioned sucrose-seeking in rats.
Cason AM; Aston-Jones G
Psychopharmacology (Berl); 2013 Mar; 226(1):155-65. PubMed ID: 23096770
[TBL] [Abstract][Full Text] [Related]
8. Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
Zhou L; Smith RJ; Do PH; Aston-Jones G; See RE
Neuropharmacology; 2012 Dec; 63(7):1201-7. PubMed ID: 22971541
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL
Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats.
Richards JK; Simms JA; Steensland P; Taha SA; Borgland SL; Bonci A; Bartlett SE
Psychopharmacology (Berl); 2008 Jul; 199(1):109-17. PubMed ID: 18470506
[TBL] [Abstract][Full Text] [Related]
11. Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking.
Smith RJ; Aston-Jones G
Eur J Neurosci; 2012 Mar; 35(5):798-804. PubMed ID: 22356621
[TBL] [Abstract][Full Text] [Related]
12. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.
Mahler SV; Smith RJ; Aston-Jones G
Psychopharmacology (Berl); 2013 Apr; 226(4):687-98. PubMed ID: 22411428
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats.
Nair SG; Golden SA; Shaham Y
Br J Pharmacol; 2008 May; 154(2):406-16. PubMed ID: 18223663
[TBL] [Abstract][Full Text] [Related]
14. Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol--preferring Sprague--Dawley rats.
Moorman DE; Aston-Jones G
Alcohol; 2009 Aug; 43(5):379-86. PubMed ID: 19671464
[TBL] [Abstract][Full Text] [Related]
15. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system.
España RA; Oleson EB; Locke JL; Brookshire BR; Roberts DC; Jones SR
Eur J Neurosci; 2010 Jan; 31(2):336-48. PubMed ID: 20039943
[TBL] [Abstract][Full Text] [Related]
16. Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice.
Fish EW; Riday TT; McGuigan MM; Faccidomo S; Hodge CW; Malanga CJ
Alcohol Clin Exp Res; 2010 Jan; 34(1):81-9. PubMed ID: 19860803
[TBL] [Abstract][Full Text] [Related]
17. Orexin-mediated restoration of hippocampal synaptic potentiation in mice with established cocaine-conditioned place preference.
Lu GL; Lee MT; Chiou LC
Addict Biol; 2019 Nov; 24(6):1153-1166. PubMed ID: 30276922
[TBL] [Abstract][Full Text] [Related]
18. N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats.
Xi ZX; Kiyatkin M; Li X; Peng XQ; Wiggins A; Spiller K; Li J; Gardner EL
Neuropharmacology; 2010 Jan; 58(1):304-13. PubMed ID: 19559037
[TBL] [Abstract][Full Text] [Related]
19. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization.
Quarta D; Valerio E; Hutcheson DM; Hedou G; Heidbreder C
Neurochem Int; 2010 Jan; 56(1):11-5. PubMed ID: 19737591
[TBL] [Abstract][Full Text] [Related]
20. Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking.
James MH; Charnley JL; Levi EM; Jones E; Yeoh JW; Smith DW; Dayas CV
Int J Neuropsychopharmacol; 2011 Jun; 14(5):684-90. PubMed ID: 21447232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
